Hepatocellular carcinoma in cirrhotic and noncirrhotic livers: A clinico-histopathologic study of 804 North American patients

American Journal of Clinical Pathology

Volumn 105, Issue 1, 1996, Pages 65-75

  Nzeako, Ugochukwu C ^a   Goodman, Zachary D ^a,b   Ishak, Kamal G ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b Veterans Administration   (United States)

Author keywords

Carcinoma; Cirrhosis: Histopathology; Epidemiology; Hepatocellular: Epidemiology, Complications; Human; Neoplasms; Prognosis; Prognosis: Mortality; Survival rate

Indexed keywords

ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

ADOLESCENT; ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CANCER SURVIVAL; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; CARCINOMA, HEPATOCELLULAR; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; HEPATITIS; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NORTH AMERICA; PREVALENCE; PROGNOSIS; SURVIVAL RATE;

EID: 0030025083     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/105.1.65     Document Type: Article

References (70)

1. Simonetti RG, Camma C, Fiorello F, et al. Hepatocellular carcinoma: A worldwide problem and the major risk factors. Dig Dis Sci 1991;36:962-972.
2. Di Bisceglie A, Rustgi VK, Hoofnagle JH, Dusheiko GM, Lotze MT. Hepatocellular carcinoma. Ann Intern Med 1988;108: 390-401.
3. Bosch FX, Munoz N. Hepatocellular carcinoma in the world: Epidemiologic questions. In: Tabor E, Di Bisceglie AM, Purcell RH, eds. Etiology, Pathology, and Treatment of Hepatocellular Carcinoma in North America. Houston: Gulf Publishing Company, 1991, pp 35-54.
4. Johnson PJ, Williams R. Cirrhosis and the aetiology of hepatocellular carcinoma. J Hepatol 1987;4:140-147.
5. Imberti D, Fornari F, Sbolli G, et al. Hepatocellular carcinoma in liver cirrhosis: A prospective study. Scand J Gastroenterol 1993;28:540-544.
6. Munoz N, Bosch X. Epidemiology of hepatocellular carcinoma. In: Okuda K, Ishak KG, eds. Neoplasms of the Liver. New York: Springer-Verlag, 1987, pp 3-19.
7. Chlebowski RT, Tong M, Weissman J, et al. Hepatocellular carcinoma: Diagnostic and prognostic features in North American patients. Cancer 1984;53:2701-2706.
8. Ihde DC, Sherlock P, Winawer SJ, Fortner JG. Clinical manifestations of hepatoma: A review of 6 years experience at a cancer hospital. Am J Med 1974;56:83-91.
9. Yamashita Y, Takahashi M, Baba Y, et al. Hepatocellular carcinoma with or without cirrhosis: A comparison of CT and angiographic presentations in the United States and Japan. Abdom Imaging 1993;18:168-175.
10. Smalley SR, Moertel CG, Hilton JF, et al. Hepatoma in the non-cirrhotic liver. Cancer 1988;62:1414-1424.
11. National Center for Health Statistics. National Death Index User's Manual. DHHS Publication No. (PHS) 90-1148. Hyattsville, MD: U.S. Department of Health and Human Services, 1990.
12. Colton T. Statistics In Medicine. Boston: Little, Brown, 1974, pp 237-250.
13. Lee ET. Statistical methods for survival data analysis. Belmont: Wadsworth, CA: 1980, pp 122-156.
14. True Epistat version 4.0. Richardson, TX: Epistat Services, 1992.
15. Ishak KG, Anthony PP, Sobin LH. Histological Typing of Tumours of the Liver: WHO International Histological Classification of Tumors, ed 2. New York: Springer Verlag, 1994.
16. Edmondson HA, Steiner PE. Primary carcinoma of the liver: Study of 100 cases among 48,900 necropsies. Cancer 1954;7: 462-503.
17. Miettinen OS. Estimability and estimation in case-referent studies. Am J Epidemiol 1976;103:226-235.
18. Hennekens CH, Buring JE. Measures of disease frequency and association. In: Mayrent SL, ed. Epidemiology in Medicine. Boston: Little, Brown, 1987, pp 77-82.
19. Gart JJ, Thomas DG. The performance of three approximate confidence limit methods for the odds ratio. Am J Epidemiol 1982;115:453-470.
20. Altman DG. Practical Statistics for Medical Research. New York: Chapman and Hall, 1991, pp 60-63.
21. Craig JR, Peters RL, Edmondson HA, Omata M. Fibrolamellar carcinoma of the liver: A tumor of adolescents and young adults with distinctive clinicopathologic features. Cancer 1980;46: 372-379.
22. Shikata T. Primary liver carcinoma and liver cirrhosis. In: Okuda K, Peters RL, eds. Hepatocellular Carcinoma. New York: John Wiley and Sons, 1976, pp 53-71.
23. Kojiro M, Nakashima T. Pathology of hepatocellular carcinoma. In: Okuda K, Ishak KG, eds. Neoplasms of the Liver. New York: Springer-Verlag, 1987, pp 81-104.
24. Vauthey J, Klimstra D, Franceschi D, et al. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 1995;169:28-34.
25. Iwatsuki S, Starzl TE, Sheahan DG, et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991;214:221-228.
26. Scudamore CH, Ragaz J, Kluftinger AM, Owen DA. Hepatocellular carcinoma: A comparison of Oriental and Caucasian patients. Am J Surg 1988;155:659-662.
27. Kew MC, Popper H. Relationship between hepatocellular carcinoma and cirrhosis. Semin Liver Dis 1984;4:136-146.
28. Johnson PJ, Krasner N, Portmann B, Eddleston AL, Williams R. Hepatocellular carcinoma in Great Britain: Influence of age, sex, HBsAg status, and aetiology of underlying cirrhosis. Gut 1978;19:1022-1026.
29. MacSween RNM. A clinicopathological review of 100 cases of primary malignant tumors of the liver. J Clin Pathol 1974;27:669-682.
30. Peers FG, Linsell CA. Dietary aflatoxins and liver cancer: A population based study in Kenya. Br J Cancer 1973;27:473-484.
31. Alpert ME, Hutt MSR, Wogan GN, Davidson CS. Association between aflatoxin content of food and hepatoma frequency in Uganda. Cancer 1971;28:253-260.
32. Peto R, Gray R, Brantom P, Grasso P. Effects on 4,080 rats of chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine: A detailed dose-response study. Cancer Res 1991;51:6415-6451.
33. Millward-Sadler GH, Hahn EG, Wright R. Cirrhosis: An appraisal. In: Wright R, Millward-Sadler GH, Alberti KG, Karran S, eds. Liver and Biliary Disease, ed 2. Philadelphia: Bailliere Tindall, 1985, pp 821-860.
34. Melia WM, Wilkinson ML, Portmann BC, Johnson PJ, Williams R. Hepatocellular carcinoma in the non-cirrhotic liver: A comparison with that complicating cirrhosis. Q J Med. New Series 1984;53:391-400.
35. Shar SR, Kew MC. Oral contraceptives and hepatocellular carcinoma. Cancer 1982;49:407-410.
36. Beasley RP. Hepatitis B virus: The major etiology of hepatocellular carcinoma. Cancer 1988;61:1942-1956.
37. Tabor E, Gerety R, Vogel CL, et al. Hepatitis B virus infection and primary hepatocellular carcinoma. J Natl Cancer Inst 1977;58: 1197-1200.
38. Popper H, Thung SN, McMahon BJ, et al. Evolution of hepatocellular carcinoma associated with chronic hepatitis B virus infection in Alaskan Eskimos. Arch Pathol Lab Med 1988;112:498-504.
39. Kew MC, Roussouw E, Paterson A, et al. Hepatitis B virus status of black women with hepatocellular carcinoma. Gastroenterology 1983;84:693-696.
40. Salonen DC, Leonhardt CM, Hemphill D, Hanna SS, Pappas SC. Radiographic features of hepatocellular carcinoma and their relation to prognosis in Canada. Can Assoc Radiol J 1994;45:35-39.
41. Falkson G, Cnaan A, Schutt AJ, Ryan LM, Falkson HC. Prognostic factors for survival in hepatocellular carcinoma. Cancer Res 1988;48:7314-7318.
42. Fortner JG, Kim DK, Maclean BJ, et al. Major hepatic resection for neoplasia: Personal experience in 108 patients. Ann Surg 1978;188:363-370.
43. Johnson PJ, Melia WM, Palmer MK, Portmann B, Williams R. Relationship between serum alphafetoprotein, cirrhosis and survival in hepatocellular carcinoma. Br J Cancer 1981;44:502-505.
44. Tanaka J, Tobe T, Morino T, Arii S, Minematsu S. Clinicopathological features of malignancy in hepatocellular carcinoma. Cancer Chemother Pharmacol 1989;23(suppl):S96-S100.
45. Nzeako UC, Goodman ZD, Ishak KG. Comparison of tumor pathology with duration of survival of North American patients with hepatocellular carcinoma. Cancer 1995;76:579-588.
46. Hoso M, Nakanuma Y. Clinicopathological characteristics of hepatocellular carcinoma bearing Mallory bodies: An autopsy study. Liver 1990;10:264-268.
47. Jensen K, Gluud C. The Mallory body: Morphological, clinical, and experimental studies (Part 1 of a literature survey). Hepatology 1994;20:1061-1077.
48. Nakanuma Y, Ohta G. Expression of Mallory bodies in hepatocellular carcinoma in man and its significance. Cancer 1986;57: 81-86.
49. Ng IOL, Lai ECS, Ng MMT, Fan ST. Tumor encapsulation in hepatocellular carcinoma: A pathologic study of 189 cases. Cancer 1992;70:45-49.
50. Okuda K, Obata H, Nakajima Y, et al. Prognosis of primary hepatocellular carcinoma. Hepatology 1984;4:3S-6S.
51. Lin DY, Liaw YF, Chu CM, et al. Hepatocellular carcinoma in noncirrhotic patients: A laparoscopic study of 92 cases in Taiwan. Cancer 1984;54:1466-1468.
52. Di Bisceglie AM, Order SE, Klein JL, et al. The role of chronic viral hepatitis in hepatocellular carcinoma in the United States. Am J Gastroenterol 1991;86:335-338.
53. Mangia A, Vallari DS, Di Bisceglie AM. Use of confirmatory assays for diagnosis of hepatitis C viral infection in patients with hepatocellular carcinoma. J Med Virol 1994;43:125-128.
54. Nakanuma Y, Terada T, Ueda K, et al. Adenomatous hyperplasia of the liver as a precancerous lesion. Liver 1993;13:1-9.
55. Ferrell LD, Crawford JM, Dhillon AP, Scheuer PJ, Nakanuma Y. Proposal for standardized criteria for the diagnosis of benign, borderline, and malignant hepatocellular lesions arising in chronic advanced liver disease. Am J Surg Pathol 1993;17: 1113-1123.
56. Foster JH, Berman MM. The malignant transformation of liver cell adenomas. Arch Surg 1994;129:712-717.
57. Institute of Laboratory Animal Resources, National Research Council. Histologic typing of liver tumors of the rat. J Natl Cancer Inst 1980;64:183-185.
58. Flejou JF, Barge J, Menu Y, et al. Liver adenomatosis: An entity distinct from liver adenoma? Gastroenterology 1985;89:1132-1138.
59. Stromeyer FW, Ishak KG. Nodular transformation (nodular "regenerative" hyperplasia) of the liver: A clinicopathologic study of 30 cases. Hum Pathol 1981;12:60-61.
60. Thorgeirsson SS, Evarts RP. Experimental hepatocarcinogenesis: Relationship between oval cells and hepatocytes in rat liver. In: Tabor E, Di Bisceglie AM, Purcell RH, eds. Etiology, Pathology, and Treatment of Hepatocellular Carcinoma in North America. Houston: Gulf Publishing, 1991, pp 171-175.
61. Ferry N, Bralet M. Oval cell lineage in chemical hepatocarcinogenesis. In: Brechet C, ed. Primary Liver Cancer: Etiological and Progression Factors. Boca Raton: CRC Press, 1994:19-27.
62. Craig JR, Klatt EC, Yu M. Role of cirrhosis and the development of HCC: Evidence from histologic studies and large population studies. In: Tabor E, Di Bisceglie AM, Purcell RH, eds. Etiology, Pathology, and Treatment of Hepatocellular Carcinoma in North America. Houston: Gulf Publishing, 1991, pp 177-190.
63. Peters RL. Pathology of Hepatocellular Carcinoma. In: Okuda K, Peters RL, eds. Hepatocellular Carcinoma. New York: John Wiley & Sons, 1976, pp 107-168.
64. Craig JR, Peters RL, Edmondson HA. Tumors of the Liver and Intrahepatic Bile Ducts. Atlas of Tumor Pathology, ed 2. Fascicle No. 26. Washington, DC: Armed Forces Institute of Pathology. 1989, pp 123-222.
65. Kashala LO, Conne B, Kalengayi MMR, et al. Histopathologic features of hepatocellular carcinoma in Zaire. Cancer 1990;65: 130-134.
66. Buscarini L, Sbolli G, Cavanna L, et al. Clinical and diagnostic features of 67 cases of hepatocellular carcinoma. Oncology 1987;44:93-97.
67. Attali P, Prod'homme S, Pelletier G, et al. Prognostic factors in patients with hepatocellular carcinoma: Attempts for the selection of patients with prolonged survival. Cancer 1987;59:2108-2111.
68. Olubuyide IO. The natural history of primary liver cell carcinoma: A study of 89 untreated adult Nigerians. Central Afr J Med 1992;28:25-30.
69. National Coordination Group of Pathology of Liver Cancer. Relationship between hepatocellular carcinoma, liver cirrhosis, and hepatitis B: A pathological study. Natl Med J China 1982;62: 257-261.
70. Kew MC. Hepatocellular carcinoma with and without cirrhosis: A comparison of Southern African Blacks. Gastroenterology 1989;97:136-139.